Sirolimus Increases T-Cell Abundance in the Sun Exposed Skin of Kidney Transplant Recipients

BACKGROUND: Kidney transplant recipients (KTRs) receiving the mammalian target of rapamycin inhibitor sirolimus may display a reduced risk of skin cancer development compared to KTRs receiving calcineurin inhibitors. Despite studies investigating the effects of these 2 drug classes on T cells in pat...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Transplant Direct
Autors principals: Burke, Michael Thomas, Sambira Nahum, Lauren C., Isbel, Nicole M., Carroll, Robert P., Soyer, Hans Peter, Francis, Ross, Bridge, Jennifer Anne, Hawley, Carmel, Oliver, Kimberly, Staatz, Christine E., Wells, James William
Format: Artigo
Idioma:Inglês
Publicat: Lippincott Williams & Wilkins 2017
Matèries:
Kidney Transplantation
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5498012/
https://ncbi.nlm.nih.gov/pubmed/28706974
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/TXD.0000000000000694
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars